Value of Adding T2 Mapping Routine MRI in Assessment of Knee Articular Cartilage Early Osteoarthritis
T2 mapping OS
Value of Adding T2mapping Sequence to Routine MRI Protocol in Assessment of Knee Articular Cartilage in Early Osteoarthritis
1 other identifier
observational
70
0 countries
N/A
Brief Summary
This work aims at elucidating the role of MRI complementary T2 mapping in assessment of the articular knee cartilage for improving sensitivity of detection of early stage of osteoarthritis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedFirst Posted
Study publicly available on registry
January 5, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 12, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
January 5, 2026
December 1, 2025
1 year
December 16, 2025
December 30, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
This work aims at elucidating the role of MRI complementary T2 mapping to measure the changes in T2 relaxation time of the articular knee cartilage in healthy group which there number will be 28 and pateints with early osteoarthritis there number 28
to detect the value of adding T2 mapping to routine MRI in assessment of the articular cartilage in knee osteoarthritis
baseline
Secondary Outcomes (1)
This work aims at quantitive stratification of osteoarthrtic changes and its impact on treatement
baseline
Interventions
Device that use coil to image asses the articular cartilage of the knee
Eligibility Criteria
any patient with knee pain with no history of previous lustrophobiaoperation and has no metallic element inside his body with no ca
You may qualify if:
- patients with clinical evidence of osteoarthritis
You may not qualify if:
- contraindications for MRI such as claustrophobia, heart pacemaker and ferromagnetic implants
- patients in which the misaligned images or distortions due to motion artifacts made the interpretation of the MRI unreliable.
- Patients with previous knee operation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Le J, Peng Q, Sperling K. Biochemical magnetic resonance imaging of knee articular cartilage: T1rho and T2 mapping as cartilage degeneration biomarkers. Ann N Y Acad Sci. 2016 Nov;1383(1):34-42. doi: 10.1111/nyas.13189. Epub 2016 Jul 29.
PMID: 27472534BACKGROUNDGao S, Peng C, Wang G, Deng C, Zhang Z, Liu X. Cartilage T2 mapping-based radiomics in knee osteoarthritis research: Status, progress and future outlook. Eur J Radiol. 2024 Dec;181:111826. doi: 10.1016/j.ejrad.2024.111826. Epub 2024 Nov 8.
PMID: 39522425BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Abeer Houssein Ali, prof.dr
Assiut University
- STUDY DIRECTOR
Ahmed Moustafa Mohamed, prof
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- DR
Study Record Dates
First Submitted
December 16, 2025
First Posted
January 5, 2026
Study Start
January 1, 2026
Primary Completion (Estimated)
January 12, 2027
Study Completion (Estimated)
February 1, 2027
Last Updated
January 5, 2026
Record last verified: 2025-12